Literature DB >> 21913048

Alzheimer's disease pathologic cascades: who comes first, what drives what.

Russell H Swerdlow1.   

Abstract

This review discusses known and speculated relationships between Alzheimer's disease (AD) biochemical, molecular, and histologic phenomena. In the AD brain, various pathologies including neuritic plaques, neurofibrillary tangles, synaptic loss, oxidative stress, cell cycle re-entry, and mitochondrial changes have all been described. In an attempt to explain what exactly goes wrong in the AD brain various investigators have proposed different heuristic and hierarchical schemes. It is important to accurately define the AD pathology hierarchy because treatments targeting the true apex of its pathologic cascade arguably have the best chance of preventing, mitigating, or even curing this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913048      PMCID: PMC3635146          DOI: 10.1007/s12640-011-9272-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  130 in total

1.  Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

Authors:  X Zhu; R J Castellani; A Takeda; A Nunomura; C S Atwood; G Perry; M A Smith
Journal:  Mech Ageing Dev       Date:  2001-12       Impact factor: 5.432

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

Review 3.  Reactive oxygen species and signal transduction.

Authors:  T Finkel
Journal:  IUBMB Life       Date:  2001-07       Impact factor: 3.885

Review 4.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

5.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

6.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

Review 7.  Structural correlates of cognition in dementia: quantification and assessment of synapse change.

Authors:  S T DeKosky; S W Scheff; S D Styren
Journal:  Neurodegeneration       Date:  1996-12

8.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  Oxidative stress increases expression and activity of BACE in NT2 neurons.

Authors:  Elena Tamagno; Paola Bardini; Alessandra Obbili; Antonella Vitali; Roberta Borghi; Damiano Zaccheo; Maria A Pronzato; Oliviero Danni; Mark A Smith; George Perry; Massimo Tabaton
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

10.  Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.

Authors:  Odity Mukherjee; John S K Kauwe; Kevin Mayo; John C Morris; Alison M Goate
Journal:  BMC Genet       Date:  2007-01-31       Impact factor: 2.797

View more
  28 in total

1.  MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.

Authors:  Sabrina Absalon; Dawn M Kochanek; Venkatesan Raghavan; Anna M Krichevsky
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

3.  Mechanisms of Evolutionary Innovation Point to Genetic Control Logic as the Key Difference Between Prokaryotes and Eukaryotes.

Authors:  William Bains; Dirk Schulze-Makuch
Journal:  J Mol Evol       Date:  2015-07-25       Impact factor: 2.395

Review 4.  Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-06       Impact factor: 21.566

Review 5.  Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions.

Authors:  Ambika Shandilya; Sidharth Mehan
Journal:  Neurol Sci       Date:  2021-05-21       Impact factor: 3.307

Review 6.  Bioenergetic medicine.

Authors:  Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

7.  Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.

Authors:  Huancun Feng; Canmao Wang; Wei He; Xinjun Wu; Shujie Li; Zhenkun Zeng; Meidan Wei; Binghong He
Journal:  Metab Brain Dis       Date:  2019-01-04       Impact factor: 3.584

8.  History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner; Magdalena Korecka; John Q Trojanowski; Leslie M Shaw
Journal:  Drug Alcohol Depend       Date:  2014-07-03       Impact factor: 4.492

9.  TREM1: A Potential Therapeutic Target For Alzheimer's Disease.

Authors:  Khalil Saadipour
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

Review 10.  The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine.

Authors:  Walter G Land
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.